Formula Pharmaceuticals licenses rights to transposon-based gene transfer technology Aug. 4, 2015 No Comments
AstraZeneca and Isis Pharmaceuticals form second antisense therapy collaboration Aug. 3, 2015 No Comments
Forge Therapeutics enters metalloprotein inhibitor pilot study with Janssen July 22, 2015 No Comments
Phylogica and the University of Queensland receive grant for macrocylic phylomer drugs July 20, 2015 No Comments